{"id":{"repo_id":"dundee","oai_identifier":"oai:discovery.dundee.ac.uk:studenttheses/ae945c78-9b73-45e9-9094-2ac91bc79590"},"canonical_url":"https://search.dev.ndltd.org/etd/dundee/oai:discovery.dundee.ac.uk:studenttheses/ae945c78-9b73-45e9-9094-2ac91bc79590","repository":{"repo_id":"dundee","name":"University of Dundee","base_url":"https://discovery.dundee.ac.uk/ws/oai"},"display":{"title":"Novel Modulators of Human Sperm Motility","abstract":"Male factor is the underlying cause in 50% cases of infertility, and is most commonly characterised by asthenozoospermia (reduced sperm motility). Incredibly, there is currently no known treatment for this condition, and the only option is Artificial Reproduction Technology (ART) which is expensive and invasive. The development of a novel treatment would fulfil a therapeutic niche that needs to be met. Using calcium as a surrogate for motility, a Flexstation high-throughput screening assay (HTS) of 3312 drug discovery ion channel compounds was performed. The screen identified 14 hit compounds that increase intracellular calcium in human spermatozoa. This project investigated these compounds, along with, 6 hit compounds previously identified from a HTS of a Chemogenomics library (246 compounds) for their potential to enhance sperm motility. One compound, Trequinsin hydrochloride (Chemogenomics library), produced statistically significant increases in progressive motility (P=0.02) instantaneously (t=0 min), an effect that was sustained for 3 hrs. Trequinsin hydrochloride, a potent class 3 phosphodiesterase inhibitor, along with B1, an ion channel compound, produced statistically significant increases in penetrating ability of spermatozoa through viscous medium. These compounds were both examined on sub-fertile patient samples, with positive results, providing preliminary data on their clinical relevance.","abstract_html":"Male factor is the underlying cause in 50% cases of infertility, and is most commonly characterised by asthenozoospermia (reduced sperm motility). Incredibly, there is currently no known treatment for this condition, and the only option is Artificial Reproduction Technology (ART) which is expensive and invasive. The development of a novel treatment would fulfil a therapeutic niche that needs to be met. Using calcium as a surrogate for motility, a Flexstation high-throughput screening assay (HTS) of 3312 drug discovery ion channel compounds was performed. The screen identified 14 hit compounds that increase intracellular calcium in human spermatozoa. This project investigated these compounds, along with, 6 hit compounds previously identified from a HTS of a Chemogenomics library (246 compounds) for their potential to enhance sperm motility. One compound, Trequinsin hydrochloride (Chemogenomics library), produced statistically significant increases in progressive motility (P=0.02) instantaneously (t=0 min), an effect that was sustained for 3 hrs. Trequinsin hydrochloride, a potent class 3 phosphodiesterase inhibitor, along with B1, an ion channel compound, produced statistically significant increases in penetrating ability of spermatozoa through viscous medium. These compounds were both examined on sub-fertile patient samples, with positive results, providing preliminary data on their clinical relevance.","abstract_has_math":false,"creators":["King, Louise"],"institution":"University of Dundee","degree_name":"Master of Science","degree_level":"Master's Thesis","degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":["Martins Da Silva, Sarah","Barratt, Christopher"],"committee_chairs":[],"committee_members":[],"year":2014,"date_issued":"2014","date_published":"2014","updated_at":"2026-07-24T02:07:59Z","subjects":["Sperm Motility","Human Sperm"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["oai:discovery.dundee.ac.uk:studenttheses/ae945c78-9b73-45e9-9094-2ac91bc79590"],"render_values":[{"text":"oai:discovery.dundee.ac.uk:studenttheses/ae945c78-9b73-45e9-9094-2ac91bc79590","href":null,"code":true}]}]},"links":{"outbound_url":"https://discovery.dundee.ac.uk/en/studentTheses/ae945c78-9b73-45e9-9094-2ac91bc79590","outbound_label":"Repository record","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Martins Da Silva, Sarah","Barratt, Christopher"]},{"key":"dc:creator","label":"Author","values":["King, Louise"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2014"]},{"key":"dc:date.issued","label":"Date","values":["2014"]},{"key":"dc:publisher.department","label":"Dc Publisher Department","values":["Centre for Biomedical Science & Public Health","Division of Cancer Research","Division of Cardiovascular & Diabetes Medicine"]},{"key":"dc:publisher.institution","label":"Dc Publisher Institution","values":["University of Dundee"]},{"key":"dc:relation.isreferencedby","label":"Dc Relation Isreferencedby","values":["https://discovery.dundee.ac.uk/en/studentTheses/ae945c78-9b73-45e9-9094-2ac91bc79590"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]},{"key":"dc:type.qualificationlevel","label":"Dc Type Qualificationlevel","values":["Master's Thesis"]},{"key":"dc:type.qualificationname","label":"Dc Type Qualificationname","values":["Master of Science"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Sperm Motility","Human Sperm"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights.embargodate","label":"Dc Rights Embargodate","values":["2016-09-24"]},{"key":"dc:rights.embargoreason","label":"Dc Rights Embargoreason","values":["/dk/atira/pure/core/document/studentthesisembargoreason/commercialexploitation"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["oai:discovery.dundee.ac.uk:studenttheses/ae945c78-9b73-45e9-9094-2ac91bc79590","https://discovery.dundee.ac.uk/en/studentTheses/ae945c78-9b73-45e9-9094-2ac91bc79590"]},{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://discovery.dundee.ac.uk/files/5594505/King_msc_2014.pdf"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Male factor is the underlying cause in 50% cases of infertility, and is most commonly characterised by asthenozoospermia (reduced sperm motility). Incredibly, there is currently no known treatment for this condition, and the only option is Artificial Reproduction Technology (ART) which is expensive and invasive. The development of a novel treatment would fulfil a therapeutic niche that needs to be met. Using calcium as a surrogate for motility, a Flexstation high-throughput screening assay (HTS) of 3312 drug discovery ion channel compounds was performed. The screen identified 14 hit compounds that increase intracellular calcium in human spermatozoa. This project investigated these compounds, along with, 6 hit compounds previously identified from a HTS of a Chemogenomics library (246 compounds) for their potential to enhance sperm motility. One compound, Trequinsin hydrochloride (Chemogenomics library), produced statistically significant increases in progressive motility (P=0.02) instantaneously (t=0 min), an effect that was sustained for 3 hrs. Trequinsin hydrochloride, a potent class 3 phosphodiesterase inhibitor, along with B1, an ion channel compound, produced statistically significant increases in penetrating ability of spermatozoa through viscous medium. These compounds were both examined on sub-fertile patient samples, with positive results, providing preliminary data on their clinical relevance."]},{"key":"dc:title","label":"Title","values":["Novel Modulators of Human Sperm Motility"]}]}],"canonical_facts":{"dc:contributor.advisor":["Martins Da Silva, Sarah","Barratt, Christopher"],"dc:creator":["King, Louise"],"dc:date":["2014"],"dc:date.issued":["2014"],"dc:description.abstract":["Male factor is the underlying cause in 50% cases of infertility, and is most commonly characterised by asthenozoospermia (reduced sperm motility). Incredibly, there is currently no known treatment for this condition, and the only option is Artificial Reproduction Technology (ART) which is expensive and invasive. The development of a novel treatment would fulfil a therapeutic niche that needs to be met. Using calcium as a surrogate for motility, a Flexstation high-throughput screening assay (HTS) of 3312 drug discovery ion channel compounds was performed. The screen identified 14 hit compounds that increase intracellular calcium in human spermatozoa. This project investigated these compounds, along with, 6 hit compounds previously identified from a HTS of a Chemogenomics library (246 compounds) for their potential to enhance sperm motility. One compound, Trequinsin hydrochloride (Chemogenomics library), produced statistically significant increases in progressive motility (P=0.02) instantaneously (t=0 min), an effect that was sustained for 3 hrs. Trequinsin hydrochloride, a potent class 3 phosphodiesterase inhibitor, along with B1, an ion channel compound, produced statistically significant increases in penetrating ability of spermatozoa through viscous medium. These compounds were both examined on sub-fertile patient samples, with positive results, providing preliminary data on their clinical relevance."],"dc:identifier":["oai:discovery.dundee.ac.uk:studenttheses/ae945c78-9b73-45e9-9094-2ac91bc79590","https://discovery.dundee.ac.uk/en/studentTheses/ae945c78-9b73-45e9-9094-2ac91bc79590"],"dc:identifier.uri":["https://discovery.dundee.ac.uk/files/5594505/King_msc_2014.pdf"],"dc:language":["eng"],"dc:publisher.department":["Centre for Biomedical Science & Public Health","Division of Cancer Research","Division of Cardiovascular & Diabetes Medicine"],"dc:publisher.institution":["University of Dundee"],"dc:relation.isreferencedby":["https://discovery.dundee.ac.uk/en/studentTheses/ae945c78-9b73-45e9-9094-2ac91bc79590"],"dc:rights.embargodate":["2016-09-24"],"dc:rights.embargoreason":["/dk/atira/pure/core/document/studentthesisembargoreason/commercialexploitation"],"dc:subject":["Sperm Motility","Human Sperm"],"dc:title":["Novel Modulators of Human Sperm Motility"],"dc:type":["Thesis"],"dc:type.qualificationlevel":["Master's Thesis"],"dc:type.qualificationname":["Master of Science"]},"updated_at":"2026-07-24T02:07:59Z"}